|
|
Article: Drug Sampling Boosts Clarinex Drug Launch; Prescription Samples Key Promotional Tool to Encourage Patient Trial, Ipsos PharmTrends(R) Report Confirms.
- Article from:
- PR Newswire
- Article date:
- August 20, 2002
CopyrightCOPYRIGHT 2002 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
UNIONDALE, NY -- The distribution of drug samples to physicians -- which accounts for about half of the pharmaceutical industry's promotional expenditures -- helped new prescription antihistamine Clarinex get into the medicine cabinets of allergy sufferers across the U.S. According to PharmTrends(R) a division of leading market research firm Ipsos-NPD, Clarinex captured a significant share of the prescription antihistamine samples distributed to patients in Q1 of 2002.
Schering-Plough, manufacturer of the Claritin and Clarinex family of prescription antihistamines for allergic rhinitis treatment, leads the category with a net 36% of the total antihistamine ...
Related newspaper, magazine, and journal articles:
|
|
Article: Rising Costs for Branded Prescription Drugs Raises Americans ...
PR Newswire;
May 12, 2004 ;
639 words
... ... health needs, the number of prescriptions filled by Americans each year continues to grow, according to new findings from Ipsos PharmTrends, a syndicated tracking study of consumer behavior by Ipsos, the global marketing research firm. However, the rate of ...
|
|